Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Pejmon, Amini"'
Publikováno v:
BMC Oral Health, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background This examiner-blind, stratified, parallel study aimed to evaluate the anti-gingivitis efficacy of a non-aqueous (anhydrous) 0.454% w/w stannous fluoride toothpaste (‘Test’) versus a sodium monofluorophosphate toothpaste (‘Co
Externí odkaz:
https://doaj.org/article/7ab2af8f07484c02bccd907d60bba56e
Publikováno v:
BMC Oral Health, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Oral Health
BMC Oral Health
Background This examiner-blind, stratified, parallel study aimed to evaluate the anti-gingivitis efficacy of a non-aqueous (anhydrous) 0.454% w/w stannous fluoride toothpaste (‘Test’) versus a sodium monofluorophosphate toothpaste (‘Control’)
Autor:
Pejmon Amini, Marcelo Werneck Barata Araujo, Mei-Miau Wu, Christine Ann Charles, Naresh Chandera Sharma
Publikováno v:
Brazilian Oral Research, Vol 23, Iss 3, Pp 319-325 (2009)
The objective of this randomized, examiner blind, parallel group, controlled clinical trial was to compare the antiplaque and antigingivitis efficacy of an essential oil-containing mouthrinse (EO) to two mouthrinses containing 0.05% Cetylpyridinium C
Externí odkaz:
https://doaj.org/article/fed65b2341914464acbba572054f00c4
Publikováno v:
Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995). 37(1)
A randomized controlled trial was conducted to evaluate the safety and efficacy of a novel 1.5% oxalate sensitivity strip. Healthy adults with dentin hypersensitivity after a cool-air challenge were randomly assigned either three sensitivity strips (
Publikováno v:
Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995). 42(2)
To assess the anti-gingivitis and anti-plaque efficacy of a novel bioavailable stannous fluoride (SnF2) dentifrice to a negative control.This was a 12-week randomized, controlled, double-blind, two-treatment, parallel group clinical study. One hundre
Autor:
James A. McGuire, John Gallob, Kimberly R Milleman, Michael C. Lynch, Roland Perfekt, Jeffery L Milleman, Pejmon Amini
Publikováno v:
The Journal of the American Dental Association. 149:608-618
Background Dentinal hypersensitivity is a prevalent oral condition that can be treated with in-office application of potassium oxalate (KO), which has US Food and Drug Administration 510(k) clearance. In this study, the authors assessed a KO mouthrin
Publikováno v:
Journal of Dentistry. 64:80-87
Objectives To explore relative efficacy of six negative-control dentifrices utilised as controls in clinical studies compared with two dentine hypersensitivity (DH)-relief dentifrices used 2×/day for 8 weeks. Methods Six control dentifrices differin
Publikováno v:
Oral healthpreventive dentistry. 16(5)
Sodium bicarbonate (NaHCO3) in toothpaste can enhance the removal of biofilms involved in the development of gingivitis. To examine this over an extended time period, this study compared the efficacy and tolerability of twice-daily brushing for 24 we
Publikováno v:
American journal of dentistry. 31(1)
To evaluate and compare gingival health, as measured by a bleeding index (BI), a modified gingival index (MGI), a dental plaque index (PI), and number of bleeding sites following twice daily use of an anhydrous 0.454% weight/weight (w/w) stannous flu
Autor:
Michael C, Lynch, Roland, Perfekt, James A, McGuire, Jeffery, Milleman, John, Gallob, Pejmon, Amini, Kimberly, Milleman
Publikováno v:
Journal of the American Dental Association (1939). 149(7)
Dentinal hypersensitivity is a prevalent oral condition that can be treated with in-office application of potassium oxalate (KO), which has US Food and Drug Administration 510(k) clearance. In this study, the authors assessed a KO mouthrinse for home